TY - JOUR AU - Hartgrink, H. H. PY - 2002 DA - 2002// TI - Value of palliative resection in gastric cancer JO - Br J Surg VL - 89 UR - https://doi.org/10.1046/j.1365-2168.2002.02220.x DO - 10.1046/j.1365-2168.2002.02220.x ID - Hartgrink2002 ER - TY - JOUR AU - Yoshida, M. PY - 2004 DA - 2004// TI - Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan clinical oncology group (JCOG) study JO - Jpn J Clin Oncol VL - 34 UR - https://doi.org/10.1093/jjco/hyh120 DO - 10.1093/jjco/hyh120 ID - Yoshida2004 ER - TY - JOUR AU - Lee, J. H. PY - 2006 DA - 2006// TI - Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan JO - Ann Surg Oncol VL - 13 UR - https://doi.org/10.1245/s10434-006-9002-3 DO - 10.1245/s10434-006-9002-3 ID - Lee2006 ER - TY - JOUR AU - Cheon, S. H. PY - 2008 DA - 2008// TI - Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases JO - Ann Onc VL - 19 UR - https://doi.org/10.1093/annonc/mdn026 DO - 10.1093/annonc/mdn026 ID - Cheon2008 ER - TY - JOUR AU - Dittmar, Y. PY - 2012 DA - 2012// TI - Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature JO - Langenbeck's Arch Surg VL - 397 UR - https://doi.org/10.1007/s00423-012-0902-3 DO - 10.1007/s00423-012-0902-3 ID - Dittmar2012 ER - TY - JOUR AU - Oyama, K. PY - 2012 DA - 2012// TI - Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes JO - J Surg Oncol VL - 105 UR - https://doi.org/10.1002/jso.22125 DO - 10.1002/jso.22125 ID - Oyama2012 ER - TY - JOUR AU - Kanda, T. PY - 2012 DA - 2012// TI - Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study JO - Gastric Cancer VL - 15 UR - https://doi.org/10.1007/s10120-011-0100-y DO - 10.1007/s10120-011-0100-y ID - Kanda2012 ER - TY - JOUR AU - Tanaka, C. PY - 2010 DA - 2010// TI - Three cases of gastric cancer with para-aortic lymph node metastases succesfully treated by S-1/CDDP combination therapy followed by curative resection JO - Gan To Kagaku Ryoho VL - 37 ID - Tanaka2010 ER - TY - JOUR AU - Suzuki, Y. PY - 2009 DA - 2009// TI - A case of marked response to CPT-11+CDDP neoadjuvant chemotherapy for advanced gastric cancer with paraaortic lymph node metastasis enabling curative resection and over 10-year survival JO - Gan To Kagaku Ryoho. VL - 36 ID - Suzuki2009 ER - TY - STD TI - Al-Batran SE, et al. Neoadjuvant chemotherapy followed by surgical resection for patients with limited metastatic gastric or gastroesophageal junction cancer: results from the AIO-FLOT3 trial. JAMA Oncology. in press; ID - ref10 ER - TY - JOUR AU - Al-Batran, S. E. PY - 2016 DA - 2016// TI - Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30531-9 DO - 10.1016/S1470-2045(16)30531-9 ID - Al-Batran2016 ER - TY - JOUR AU - Fujitani, K. PY - 2016 DA - 2016// TI - Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial JO - Lancet Oncol. VL - 17 UR - https://doi.org/10.1016/S1470-2045(15)00553-7 DO - 10.1016/S1470-2045(15)00553-7 ID - Fujitani2016 ER - TY - JOUR AU - Homann, N. PY - 2012 DA - 2012// TI - Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel JO - Int J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.26180 DO - 10.1002/ijc.26180 ID - Homann2012 ER - TY - JOUR AU - Schulz, C. PY - 2015 DA - 2015// TI - NeoFLOT: multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma—very good response predominantly in patients with intestinal type tumors JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29403 DO - 10.1002/ijc.29403 ID - Schulz2015 ER -